Cite
HARVARD Citation
Wang, X. et al. (2016). Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis. Journal of clinical pharmacology. pp. 628-636. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, X. et al. (2016). Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis. Journal of clinical pharmacology. pp. 628-636. [Online].